A detailed history of 1832 Asset Management L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, 1832 Asset Management L.P. holds 405 shares of TEVA stock, worth $6,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
405
Previous 405 -0.0%
Holding current value
$6,929
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $1,067 - $1,443
-100 Reduced 19.8%
405 $5,000
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $811 - $1,063
100 Added 24.69%
505 $5,000
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $3,029 - $4,333
405 New
405 $4,000
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $4,116 - $7,170
-600 Reduced 59.7%
405 $3,000
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $4,428 - $6,240
600 Added 148.15%
1,005 $8,000
Q4 2021

Feb 15, 2022

SELL
$7.9 - $10.19 $1,580 - $2,038
-200 Reduced 33.06%
405 $3,000
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $1,676 - $2,036
200 Added 49.38%
605 $6,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $2,644 - $4,341
405 New
405 $4,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $527,800 - $1.02 Million
-65,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $1.01 Million - $1.3 Million
64,945 Added 118081.82%
65,000 $1.02 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $834,000 - $1.1 Million
-50,000 Reduced 99.89%
55 $1,000
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $281,704 - $479,123
-25,085 Reduced 33.38%
50,055 $945,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1.16 Million - $2.42 Million
75,140
75,140 $1.28 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.